If we get everything mentioned above we will be in the 40’s. I also wonder if the FDA guidance on Alzheimer’s and the peer review process has been hindered by the new FDA guidelines.
Going to the $40's? Making excuses for the peer review delay? IMO that's a FOMO building pumping post. All we are likely to get is Missling selling more shares. His actions actually help depress the share price.